Miglustat Capsule
Product Images NDC 10148-201

2 FDA label images from Cotherix, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Miglustat (NDC 10148-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cotherix, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Miglustat 01)

Chemical Structure (Miglustat 01)
Chemical structure of miglustat. The diagram shows a six-membered ring containing a nitrogen atom, with hydroxyl groups attached at positions 3, 4, 5, and 11, and a methyl group attached via a side chain at position 9.*
FDA Label Image

Principal Display Panel (100 mg Capsule Blister Pack Carton)

Principal Display Panel (100 mg Capsule Blister Pack Carton)
Miglustat 100 mg capsules packaging label for oral use. The carton includes the brand name migLUstat, strength of 100 mg per capsule, and states the package contains 90 capsules in six blister cards of 15 capsules each. Manufactured for CoTherix, Inc., distributed by Patriot Pharmaceuticals, LLC, and made in Switzerland. The label notes the capsules contain 100 mg miglustat, inactive ingredients, and storage instructions. It also indicates the package is not child resistant and is Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.